Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Hughes

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Hematology. American Society of Hematology. Education Program|November 25, 2006
ABL kinase inhibitor therapy for CML: baseline assessments and response monitoringTimothy Hughes
Nature Clinical Practice. Oncology|October 18, 2007
Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?Timothy Hughes
Methods in Molecular Medicine|March 1, 2006
Diagnosis and monitoring of chronic myeloid leukemia by qualitative and quantitative RT-PCRSusan Branford, Timothy Hughes
Methods in Molecular Medicine|March 1, 2006
Detection of BCR-ABL mutations and resistance to imatinib mesylateSusan Branford, Timothy Hughes
Genome Biology|August 14, 2003
From microarrays to genome duplicationsChristian Roth, Timothy Hughes
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2006
Role of allogeneic stem cell transplantation for adult chronic myeloid leukemia in the imatinib eraAndrew Grigg, Timothy Hughes
Hematology. American Society of Hematology. Education Program|December 10, 2013
Which TKI? An embarrassment of riches for chronic myeloid leukemia patientsTimothy Hughes, Deborah White
Seminars in Hematology|July 23, 2009
Clinical strategies to achieve an early and successful response to tyrosine kinase inhibitor therapyTimothy Hughes, Andreas Hochhaus
Blood Reviews|January 24, 2006
Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemiaTimothy Hughes, Susan Branford
Current Opinion in Hematology|January 12, 2010
Managing imatinib resistance in chronic myeloid leukaemiaMichael Osborn, Timothy Hughes
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Hematology. American Society of Hematology. Education Program|November 25, 2006
ABL kinase inhibitor therapy for CML: baseline assessments and response monitoringTimothy Hughes
Nature Clinical Practice. Oncology|October 18, 2007
Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?Timothy Hughes
Methods in Molecular Medicine|March 1, 2006
Diagnosis and monitoring of chronic myeloid leukemia by qualitative and quantitative RT-PCRSusan Branford, Timothy Hughes
Methods in Molecular Medicine|March 1, 2006
Detection of BCR-ABL mutations and resistance to imatinib mesylateSusan Branford, Timothy Hughes
Genome Biology|August 14, 2003
From microarrays to genome duplicationsChristian Roth, Timothy Hughes
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2006
Role of allogeneic stem cell transplantation for adult chronic myeloid leukemia in the imatinib eraAndrew Grigg, Timothy Hughes
Hematology. American Society of Hematology. Education Program|December 10, 2013
Which TKI? An embarrassment of riches for chronic myeloid leukemia patientsTimothy Hughes, Deborah White
Seminars in Hematology|July 23, 2009
Clinical strategies to achieve an early and successful response to tyrosine kinase inhibitor therapyTimothy Hughes, Andreas Hochhaus
Blood Reviews|January 24, 2006
Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemiaTimothy Hughes, Susan Branford
Current Opinion in Hematology|January 12, 2010
Managing imatinib resistance in chronic myeloid leukaemiaMichael Osborn, Timothy Hughes
Pageof 15